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Rhesus macaqueLate adolescence in males is a period of increased susceptibility for the onset of schizophrenia, coinciding with
increased circulating testosterone. The cognitive deﬁcits prevalent in schizophrenia may be related to unhealthy
cortical interneurons, which are trophically dependent on brain derived neurotrophic factor. We investigated,
under conditions of depleted (monkey and rat) and replaced (rat) testosterone over adolescence, changes in
gene expression of cortical BDNF and TrkB transcripts and interneuron markers and the relationships between
these mRNAs and circulating testosterone. Testosterone removal by gonadectomy reduced gene expression of
some BDNF transcripts in monkey and rat frontal cortices and the BDNF mRNA reduction was prevented by
testosterone replacement. In rat, testosterone replacement increased the potential for classical TrkB signalling
by increasing the full length to truncated TrkB mRNA ratio, whereas in the monkey cortex, circulating testoster-
onewas negatively correlatedwith the TrkB full length/truncatedmRNA ratio.We did not identify changes in in-
terneuron gene expression inmonkey frontal cortex in response to gonadectomy, and in rat, we showed that only
somatostatinmRNAwas decreased by gonadectomy but not restored by testosterone replacement.We identiﬁed
complex and possibly species-speciﬁc, relationships between BDNF/TrkB gene expression and interneuron marker
gene expression that appear to be dependent on the presence of testosterone at adolescence in rat and monkey
frontal cortices. Taken together, our ﬁndings suggest there are dynamic relationships between BDNF/TrkB and in-
terneuron markers that are dependent on the presence of testosterone but that this may not be a straightforward
increase in testosterone leading to changes in BDNF/TrkB that contributes to interneuron health.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Adolescence is a period of increasing circulating sex steroids aswell as
a period of brain development andmaturation that contributes to chang-
es in behaviour, cognition and social interactions (Spear, 2000; Sisk and
Zehr, 2005; Richards et al., 2009; Schulz et al., 2009). Late adolescence
inmales is a period of greater susceptibility for the onset of schizophrenia
compared to females— coincidingwith increased circulating testosterone
(Gaidano et al., 1980; Markham, 2012). In addition, males, as shown by
two meta-analyses, have an overall ~40% greater chance of developing
schizophrenia than females (Aleman et al., 2003; McGrath et al., 2004),oratory, Neuroscience Research
. This is an open access article underhave a worse course of the disease and are more treatment resistant
(McGrath et al., 2008). This raises questions about how testosterone con-
tributes to normal brain changes thatmay be relevant to the precipitation
and progression of schizophrenia possibly in those individuals with an
underlying (genetic) susceptibility to schizophrenia.
Cognitive deﬁcits are a core feature of schizophrenia (Weickert et al.,
2000) and are present throughout the adult life ofmost individualswith
schizophrenia, including a typical drop in cognitive ability prior to the
initial onset of psychosis, and thus, prior to antipsychotic treatment
(Saykin et al., 1994; Davidson et al., 1999; Bora and Murray, 2014).
Cognitive deﬁcits include impairments in executive function, and
working memory, abilities which are coordinated by cortical circuits,
particularly in the prefrontal cortex (Levy and Goldman-Rakic,
2000). Cortical circuits are composed of two types of neurons, excitatorythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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interneurons (Parnavelas, 2000; Lodato et al., 2014). Inhibitory inter-
neurons use γ-aminobutyric acid (GABA) as a neurotransmitter and are
crucial for the coordination and synchronization of excitatory neuron ac-
tivity during working memory processes (Lewis and Hashimoto, 2007).
Interneuron health is compromised in schizophrenia as evidenced by
reduced gene expression and protein levels of glutamic acid decarboxyl-
ase (GAD67), an enzyme that synthesizes GABA, in the dorsolateral
prefrontal cortex (DLPFC) of individuals with schizophrenia (Akbarian
et al., 1995; Woo et al., 1998; Guidotti et al., 2000; Lewis et al., 2004b;
Thompson et al., 2009; Duncan et al., 2010). These cortical GABAergic
inhibitory interneurons are a heterogeneous population of neurons
that vary based on morphology, electrophysiological properties, laminar
distribution, innervation of pyramidal neurons and expression of neuro-
peptides and calcium binding proteins (Markram et al., 2004; Petilla
Interneuron Nomenclature GROUP, 2008). Three largely independent
populations of interneurons expressing i) parvalbumin (PV), ii)
somatostatin/calbindin (SST/CB) and iii) calretinin/vasoactive intesti-
nal peptide (CR/VIP) have been identiﬁed (Somogyi et al., 1998).
Expression of many biochemical markers of inhibitory interneurons is
often reduced in postmortem cortex from schizophrenia patients
including PV, SST, cholecystokinin (CCK), neuropeptide Y (NPY), and
VIP (Hashimoto et al., 2003, 2008a,b; Morris et al., 2008; Fung et al.,
2010, 2014; Joshi et al., in press) indicating functional deﬁcits in cortical
interneurons. On the other hand, CB expressionmay be increased in the
DLPFC as found in three separate post mortemDLPFC cohorts in schizo-
phrenia (Daviss and Lewis, 1995; Fung et al., 2010, 2014). Reports of
decreased SST and PV gene expression appear to be the most robust
and consistently reported in schizophrenia (Beasley and Reynolds,
1997; Lewis, 2000; Cotter et al., 2002; Hashimoto et al., 2008a,b; Morris
et al., 2008; Fung et al., 2010, 2014). These two interneuron populations
are known to be trophically dependent on BDNF/TrkB (Altar et al.,
1997; Hashimoto et al., 2005; Glorioso et al., 2006; Woo and Lu, 2006).
Interneurons express tropomyosin related kinase (TrkB) and require
pyramidal neuron synthesized brain derived neurotrophic factor
(BDNF) for differentiation and maturation (Glorioso et al., 2006). Reduc-
tions in gene expression and protein level of both BDNF and its cognate
tyrosine kinase receptor, TrkB, have been identiﬁed in the DLPFC of indi-
viduals with schizophrenia and these reductions have been proposed to
contribute to the reduced health of interneurons in schizophrenia
(Weickert et al., 2003, 2005; Hashimoto et al., 2005; Lewis et al., 2005;
Wong et al., 2010; Ray et al., 2014). A recent meta-analysis has also
shown that BDNF blood levels are reduced in both medicated and drug-
naïve patients with schizophrenia (Green et al., 2011). Deﬁcits in BDNF
and TrkB have been linked to reduced GABAergic neuron density, re-
duced GAD67 gene expression, fewer GABAergic terminals and lower
levels of somatostatin and parvalbumin in rodents (Huang et al., 1999;
Villuendas et al., 2001; Glorioso et al., 2006; Arango-Gonzalez et al.,
2009).
There is evidence to suggest that testosterone is able to modulate
brain BDNF levels (Pluchino et al., 2013). Indeed, testosterone modulates
BDNF and TrkB expression in the adult rodent cortex and songbird higher
vocal centre (Rasika et al., 1999; Verhovshek et al., 2010; Hill et al., 2012).
In the forebrain ofmalemice, increases in BDNF expression corresponded
in time to the surge in testosterone at adolescence; and conversely, there
was a signiﬁcant decrease of TrkB protein with increased testosterone in
the cortex (Hill et al., 2012). As such, the evidence that TrkB andBDNF sig-
nalling are reduced and interneuron health is compromised in schizo-
phrenia, which raises the possibility of a role for testosterone in the
pathophysiology of schizophrenia possibly via a reduction of cortical
BDNF/TrkB expression levels ultimately impacting cortical interneurons.
However, it is not known how testosterone and BDNFmRNAs are related
to interneuron health in normal adolescent prefrontal cortex.
In normal male Sprague–Dawley rats and rhesus macaques, we in-
vestigated whether circulating testosterone during adolescence modu-
lates gene expression of BDNF and TrkB, and we asked whether thiswas related to gene expression of interneuron speciﬁc genes — the ex-
pression of which is thought to be an index of the function of interneu-
rons. The BDNF gene, in both rat and primate, can generate multiple
transcripts by alternate splicing of 5′ exons (exons I–VIII)with the com-
mon 3′ exon IX (Aid et al., 2007; Pruunsild et al., 2007). All BDNFmRNA
transcripts result in the same mature BDNF protein but the distinct
alternate 5′ promoters enable distinct temporal and tissue speciﬁc
expression and possibly different subcellular localization (Aid et al.,
2007 a; Nanda andMack, 1998;Wong et al., 2010). BDNF initiates intra-
cellular signalling by binding to, and thereby activating, TrkB (Barbacid,
1994). However, truncated TrkB receptors that lack the tyrosine kinase
domain have been identiﬁed in humans, non-human primates and ro-
dents (Middlemas et al., 1991; Luberg et al., 2010; Wong et al., 2013)
and are considered to be BDNF sinkswhereby they bind BDNF preventing
it frombinding to and signalling via functional (full length) TrkB receptors
(Eide et al., 1996). Although there is evidence that truncated TrkB pro-
teins may activate alternate signalling pathways (Fenner, 2012).
In this study, we measured gene expression of the most highly
expressed BDNF transcripts in the primate (monkey) (Aid et al., 2007;
Pruunsild et al., 2007) and the rat cortex (Aid et al., 2007) under condi-
tions of depleted (monkey and rat) and replaced testosterone (rat).
We also measured gene expression of full length TrkB in both species
(monkey: TrkB.TK+; rat: TrkB.FL), a single truncated TrkB isoform in
monkey (TrkB.TK−) (Ohira and Hayashi, 2003; Ohira et al., 2005) and
two truncated TrkB isoforms (TrkB.T1 and T2) in rats (Middlemas
et al., 1991) to test if testosterone can inﬂuence cortical gene expression
or splice variant levels of TrkB mRNA. Further, we asked whether
changes in BDNF or TrkB transcripts are related to interneuron marker
expression in either species. We measured PV, SST, CB and CR gene
expression, which captures three largely independent populations of
interneurons (Somogyi et al., 1998). Determiningwhether testosterone
modulates neurotrophinmRNAs in relationship to interneuronmarkers
that are involved in normal cortical maturation at adolescence may
provide clues as to why adolescence is a period of risk for pathophys-
iology of cortical deﬁcits that can be identiﬁed in those with chronic
schizophrenia.
2. Methods
2.1. Experimental animals
2.1.1. Rhesus macaques
All procedures involving rhesus macaques were approved by the
National Institute ofHealth (NIH)Animal Care andUse Ethics Committee.
A total of twelve experimentally naive male rhesus macaque monkeys
(Macaca mulatta) from the NIH Animal Centre's primate ﬁeld station
were used in the study, andwere divided into two social groups. Subjects,
housing conditions, surgery and endocrine measurements have been
described in detail in Richards et al. (2009). 29 month old (~2.4 years)
monkeys, showing no overt signs of puberty and testosterone levels
less than 0.06 ng/ml were either gonadectomised (gdx, n = six) or
sham-operated (intact, n= six) with a monkey from each group under-
going a yoked surgery (simultaneous anaesthesia, timing and recovery).
Thus, sham animals underwent the same anaesthesia protocol but did
not have any surgical manipulations performed. Blood samples were
drawn every six–eight weeks beginning one month prior to surgery
and continuing to the conclusion of the study. Samples were taken at
9:30 am and 11:00 pm, to track the diurnal variations in testosterone in
addition to the seasonal variations. The average nighttime (pm) testos-
terone level (i.e., 11 pm measurement) has been used in this study as
daily circulating testosterone is highest at night. In intact monkeys, the
average pm testosterone was 14.29 ± 1.53 ng/ml and this was reduced
to 0.15 ± 0.01 ng/ml in the gonadectomised group. At 55 months of
age (4.6 years) monkeys were saline perfused, brains were cut into
1 cm coronal sections and frozen. The fresh frozen tissue block containing
frontal pole tissue was pulverized for homogenate studies and 14 μm
Table 1
TaqMan gene expression assays.
Gene Monkey Rat
TrkB-TK+
TrkB.FL
Hs0193098_m1 Rn00820626_m1
TrkB-TK− Hs0193110_m1
TrkB.T1 AJSO7AX
TrkB.T2 AJRR84P
BDNF I Hs00538277_m1 Rn01484924_m1
BDNF II Hs00538278_m1
BDNF IIA Rn00560868_m1
BDNF IIB Rn01484926_m1
BDNF IIC Rn01484925_m1
BDNF IV Rn01484927_m1
BDNF VI Hs00601650_m1 Rn01484928_m1
PV Hs00161045_m1 Rn00574541_m1
SST Hs00356144_m1 Rn00561967_m1
CB Hs01077191_m1 Rn00583140_m1
CR Hs00242372_m1 Rn00588816_m1
SDHA Hs01549169_m1
TBP Hs0042760_m1
YWHAZ Rn00755072_m1
GUSB Rn00566655_m1
18S rRNA Hs99999901
GAPDH Rn01775763
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cortex containing theprinciple sulcus and tissuewas thaw-mounted onto
gelatinised glass slides for in situ hybridization studies (Brain Research
Laboratories, Newton, MA).
2.1.2. Sprague–Dawley rats
All rat experiments were approved by the Animal Care and Ethics
Committee of the University of New South Wales in accordance with
the National Health and Medical Research Council of Australia's Code
of Practice for the Care and Use of Animals for Experimental Purposes,
which also conforms to standard international guidelines. Male
Sprague–Dawley rats were used for all experiments (Animal Resource
Centre, Perth, WA, Australia). Rats arrived at 32/33 days of age at our
facility and were group housed (3–4/cage) in 12/12 h light/dark phases
with constant humidity and temperature and free access to water and
standard rat chow.
Adolescent male rats were gonadectomised at 45 days of age, prior to
the adolescent testosterone increase (Saksena and Lau, 1979; Walker
et al., 2012), and given continuous replacement testosterone (T) by sub-
dermal silastic implant (Zirkin et al., 1989; Singh et al., 1995; Allan et al.,
2010) for twoweeks. By this age (60 days of age), intact animals have ex-
perienced the increase in testosterone associated with adolescence
(Saksena and Lau, 1979; Walker et al., 2012). There were three groups
(12–15 rats per group): intact (Intact), gonadectomy alone (Gdx) and
gonadectomy plus testosterone (Gdx + T). Male rats (45 days old)
were anaesthetized with an intraperitoneal (i.p.) injection of ketamine
hydrochloride (60 mg/kg) and xylazine hydrochloride (10 mg/kg)
(Provet, Castle Hill, Australia). The intact animals underwent sham
abdominal surgery but gonads were left in place. Silastic implants were
placed under the skin between the shoulder blades at time of gonadec-
tomy. Gdx and Intact groupswere given empty implants. Implantswere
1 cm long, and have an internal diameter of 1.47 mm, and outer diam-
eter of 1.95 mm (ends sealed with silastic adhesive). These implants
have been characterized in previous studies and achieve
supraphysiological, steady-state hormone levels and maintain seminal
vesicle weights equal to that in untreated animals (Singh et al., 1995;
Purves-Tyson et al., 2007). Seminal vesicles depend on androgen action
for normal development and maintenance of structural and functional
integrity (Mooradian et al., 1987). Weight of seminal vesicles at the
end of experiment served as an index of the restoration of androgen ac-
tion by the implants as previously reported (Purves-Tyson et al., 2007).
Serum testosterone levels and seminal vesicle weights were used to
conﬁrm successful gonadectomy, and have been described in Purves-
Tyson et al. (2012). Average circulating serum testosterone was 0.03 ±
0.001 ng/ml in the Gdx group (n = 9), 2.8 ± 0.6 ng/ml (n = 12) in the
Intact group and 23.1 ± 12.0 ng/ml in the Gdx + T group (n = 14).
Gonadectomy reduced seminal vesicles to 9.0% of the weight of the
Intact group. Seminal vesicles were maintained at 94.2% of intact
weights by replacement testosterone.
At 60 days of age rats were anaesthetized with 60 mg/kg sodium
pentobarbital (Euthal, Delvet, Seven Hills, Australia). The brain was re-
moved from the skull and a tissue block containing the frontal cortex
was dissected following the Rat Brain Atlas as a guide (Paxinos and
Watson, 2007). The frontal cortex block was trimmed such that cingu-
late, infralimbic and premotor cortices were collected for RNA extrac-
tion. Trunk blood was collected on day of euthanasia in 0.8 ml serum
gel tubes (Z serum sep MiniCollect tube, Greiner Bio One, Wemmel,
Belgium) and serum was collected by centrifugation after 30–60 min
at room temperature.
2.2. RNA extraction and cDNA synthesis
Total RNAwas extracted from frontal cortex samples in 800–1000 μl
TRIzol reagent (Life Technologies Inc., Grand Island, NY, USA) as recom-
mended by the manufacturer. RNA was quantiﬁed using a ND-1000
Spectrophotometer (Nanodrop Technologies, Wilmington, USA). RNAintegrity (RIN) was assessed with high resolution capillary electropho-
resis (Agilent Bioanalyzer 2100, Agilent Technologies, Palo Alto, CA,
USA). Rat samples: Two separate aliquots of 3 μg RNA from each sample
were reverse transcribed to cDNA with SuperScript III First-Strand Syn-
thesis Supermix and randomhexamers, according to themanufacturer's
protocol (Life Sciences) and pooled. Monkey samples: 3 μg RNA from
each sample was reversed transcribed to cDNA with SuperScript II
First-Strand Synthesis Supermix and random hexamers, according to
themanufacturer's protocol (Life Technologies). In both rat andmonkey
samples, a parallel reaction was performed without reverse transcrip-
tase as a genomic DNA ampliﬁcation control.2.3. Quantitative real-time PCR (qPCR)
Messenger RNA (mRNA) levels of genes of interest were measured
by TaqMan Gene Expression Assays (Applied Biosystems, Foster City,
CA, USA) using an ABI Prism 7900HT Fast Real-Time PCR System
and a 384-well format. Expression of four housekeeping genes, tyrosine
3-monooxygenase/tryptophan 5-monooxygenase activation protein
(YWAZ), beta-glucoronidase (GusB), 18S ribosomal RNA (18S rRNA)
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH), was used
to calculate the normalizing control for rat gene expression (termed
geometric mean), and were selected on the basis that they were un-
changed by the treatment (Table 1).
The geometricmean of the four housekeeping genes usedwas calcu-
lated as described previously (Vandesompele et al., 2002). There were
no group differences when the geomean of the three housekeepers
was compared (F = 1.67, df = 4, p = 0.17). For monkey, SHDA, ACTB
and TBP were used as the normalizing control for gene expression,
andwere selected on the basis that theywere unchanged by gonadecto-
my [t(10) = 1.79, p = 0.10].
Genes of interest were targeted by TaqMan probes and listed in
Table 1 (Applied Biosystems). Samples were run alongside a seven
point standard curve using serial dilutions of pooled cDNA derived
from PFC mRNA pooled from a subset of 25 rats (taken from all treat-
ment groups) (Purves-Tyson et al., 2012) or pooled from all monkeys.
No template controls were included which produced no signal for any
mRNA examined. Measurements were performed in triplicate. PCR cy-
cling conditions were: 50 °C for 2 min, 95 °C for 10 min, 50 cycles at
95 °C for 15 s and 60 °C for 1 min. PCR data were captured with Se-
quence Detector Software (SDS version 2.4, Applied Biosystems). SDS
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within the linear phase of the ampliﬁcation proﬁles.
2.4. In situ hybridisation
Antisense riboprobes were generated for BDNF II and BDNF VI by
amplifying transcript speciﬁc DNA fragments from cDNA using the
following primer sets:
BDNF II forward 5′-TATCTCCAGGATCTAGCCACC-3′
BDNF VI forward 5′-ATCGGAACCACGATGTGACTCC-3′
BDNF common reverse 5′-ATCCAACAGCTCTTCTATCACG-3′.
Plasmids were constructed by annealing PCR products into a PCRII
vector using the PCRII TA cloning kit (Invitrogen, CA, USA) as per
manufacturer's instructions. Riboprobes were synthesized from
linearised plasmid using SP6 and T7 polymerases respectively and an
in vitro transcription kit as recommended by the manufacturer
(Promega, WI, USA). Antisense and sense riboprobes were labelled
to a speciﬁc activity of ~2 × 109 cpm/μg by addition of radiolabelled
[35S]rUTP (Perkin Elmer,Melbourne, Australia) andwere puriﬁedby eth-
anol precipitation. 14 μm coronal sections containing the frontal cortex
were used for in situ hybridisation histochemistry as previously de-
scribed (Whitﬁeld et al., 1990) using two slides per region per mon-
key. After hybridisation and washing steps, sections were exposed
to autoradiographic ﬁlm (Bio-Max, Kodak) for 2 months. All sections
were assayed together to limit inter assay variability.
Calibrated densitometric analysis (ImageJ, NIH) was conducted
blind to treatment group. Slideswere ﬁrst calibrated to radioactive stan-
dards (American Radiolabeled Chemicals Inc., MO, USA). In the dorsal
bank of the principal sulcus on each section, three randomly placed
lines were drawn perpendicular to the pial surface, traversing the entire
cortical greymatter. The density of target mRNA as a function of cortical
depth was computed from continuous optical density measurements
recorded along the length of these lines. The percentage of full cortical
width corresponding to the individual lamina was determined from
published guidelines as follows: I (2–6%), II (14–18%), III (20–42%), IV
(46–50%), V (54–68%) and VI (72–92%) (Kritzer and Goldman-Rakic,
1995; Rajkowska and Goldman-Rakic, 1995; Romanczyk et al., 2002).
2.5. Statistics
Statistical analyses were conducted using GraphPad (version 6) and
Statistica (version 12) and p ≤ 0.05 was considered statistically signiﬁ-
cant. Rat qPCR data are presented as percent change of mRNA levels rel-
ative to the Intact group ± SEM. Outlier detection of the triplicates
obtained from the qPCR raw data was used to exclude measurement
error (Weickert et al., 2010). qPCR raw data was normalized by the
geomean of the housekeepers. Population outliers were removed by
performing Grubb's test on the normalized data and data were analysed
by one-way ANOVA followed by Fisher's LSD. Monkey qPCR data was
analysed with two-tailed independent sample t-tests to determine the
difference in mRNA expression between intact and gonadectomised
monkeys, data are presented as percent change in mRNA levels relative
to the intact group ± SEM.
In situ hybridization density measurements were analysed by
repeated measures ANOVA with “treatment” (Intact vs Gdx) as the be-
tween subjects factor and “layer” (I–VI) as the within subjects factor.
Signiﬁcant interactions were followed up with Fisher's least signiﬁcant
differences post hoc analysis.
In the Intact monkey group, Pearson's correlations were performed
to analyse the relationship between testosterone and neurotrophin
transcripts, receptor transcripts and interneuron marker expression.
Pearson's correlations were also used to determine changes in the rela-
tionship between interneuron markers and neurotrophin and receptortranscripts in Intact and testosterone replaced (rat only) and Gdx
groups monkey and rat groups.
3. Results
3.1. Testosterone reverses gonadectomy-induced increases in selective
BDNF transcripts in the rat and monkey frontal cortices
Investigation of BDNF II and BDNF VI mRNA transcript expression in
the monkey prefrontal cortex by in situ hybridization revealed that tes-
tosterone removal during adolescence resulted in an increase in both
transcripts. There was a main effect of group (Gdx vs. Intact) for both
BDNF II and BDNF VI [BDNF II mRNA, F(1,9) = 16.19, p = 0.003 and
BDNF VI mRNA, F(1,10) = 22.90, p = 0.0007] as well as a signiﬁcant
interaction between group and layer for both transcripts [BDNF II
mRNA, F(6,54) = 4.780, p = 0.0006 and BDNF VI mRNA, F(6,60) =
4.79, p= 0.0005]. Post hoc comparisons revealed signiﬁcant differences
between gonadectomy and intact groups in all layers for both tran-
scripts except for layer I (Fig. 1C and D).
To further investigate the effect of testosterone removal and replace-
ment on BDNF gene expression, we investigated the effect on rodent
cortex. In the rat, exon II gives rise to three distinct transcripts due to
alternate donor splice sites (Aid et al., 2007), and transcripts IIa, IIb
and IIc were measured in the rat. There was an effect of treatment
group on BDNF IIa mRNA expression [F(2,43) = 3.57, p = 0.04]
(Fig. 2A). Gonadectomy of male rats during adolescence revealed a
signiﬁcant 22.7% increase in BDNF-IIa mRNA expression in the
gonadectomised group compared to the Intact group (Gdx vs. Intact,
p = 0.02) and this increase was attenuated by testosterone replacement
(Intact vs Gdx + T, p = ns; Gdx vs. Gdx + T, p = 0.045). In contrast,
neither gonadectomy nor testosterone replacement resulted in a signiﬁ-
cant change in expression of BDNF IIb [F(2,42) = 0.06, p = 0.90] or
BDNF IIc [F(2,42) = 1.08, p = 0.35] (data not shown). There was no
signiﬁcant effect of treatment group on gene expression of BDNF-VI
[F(2,42) = 1.96, p = 0.15]. However, due to an a priori hypothesis
based on ﬁndings in rhesus macaque, post hoc tests were carried out
which revealed that testosterone replacement reduced BDNF-VI gene
expression by 15% compared to gonadectomised rats (Gdx vs. Gdx + T,
p = 0.05) (Fig. 2B). The expression levels of BDNF-I [F(2,42) = 0.08,
p = 0.9] and BDNF-IV [F(2,43) = 0.14, p = 0.87] did not appear to be
changed by gonadectomy and testosterone replacement (data not
shown).
3.2. Testosterone modulates the relationship of full length to truncated TrkB
mRNA in the rat and monkey frontal cortices
Analysis of gene expression in rodent frontal cortex, using qPCR,
revealed no effect of treatment group when examining full length
TrkB (TrkB.FL) [F(2,44)=2.38, p=0.11]mRNAor truncated TrkB tran-
script T1 [TrkB.T1, F(2,42) = 0,95, p = 0.40] expression (data not
shown). However, there was a signiﬁcant effect of treatment group on
truncated TrkB transcript 2 [TrkB.T2, F(2,43) = 3.32, p = 0.046]
(Fig. 3A). Testosterone removal increased TrkB.T2 by 28%, but this did
not reach statistical signiﬁcance (Intact vs Gdx, p = 0.13), however,
testosterone replacement signiﬁcantly reduced the level of TrkB.T2
mRNA by 46.2% compared to gonadectomised rats (Gdx vs Gdx + T,
p = 0.014) (Fig. 3A left).
In the rat, there was no effect of treatment group on the TrkB.FL:
TrkB.T1 (TrkB FL:T1) ratio [F(2,43) = 0.68, p = 0.51] (data not shown),
whereas there was a signiﬁcant effect of treatment group on TrkB.FL:
TrkB.T2 (TrkB FL:T2) ratio [F(2,43)=3.97, p=0.026] (Fig. 3A right). Go-
nadectomy reduced the ratio of TrkB FL:T2mRNA compared to intact an-
imals by 37% (Intact vs. Gdx, p = 0.027) and the testosterone replaced
group was not signiﬁcantly different to the intact group but was in-
creased 40% compared to the gonadectomised group (Intact vs.
Gdx + T, p = ns; Gdx vs. Gdx + T, p = 0.012) (Fig. 3A left).
Fig. 1.Modulation of BDNF II andVImRNAexpression in rhesusmacaque frontal cortex. The representative in situhybridisation panels showBDNF II (A) and BDNFVI (B)mRNAexpression
in the frontal cortex of gonadectomised monkeys. Lower magniﬁcation panels show the principal sulcus of the frontal cortex (scale bar = 250 μm) and the higher magniﬁcation boxes
show thedorsal bank of the principal sulcus. Three randomly placed lineswere drawn perpendicular to thepial surface in thedorsal bank, traversing thewhole greymatter and thedensity
of targetmRNAwasmeasured (seeMethods). Therewas amain effect of group (gdx vs. intact) for both BDNF II (C) and BDNFVI (D) [BDNF IImRNA, F(1,9)=16.19, p=0.003 and BDNFVI
mRNA, F(1,10) = 22.90, p = 0.0007] as well as a signiﬁcant interaction between group and layer for both transcripts [BDNF II mRNA, F(6,54) = 4.780, p = 0.0006 and BDNF VI mRNA,
F(6,60) = 4.79, p = 0.0005]. Fisher's LSD post hoc revealed signiﬁcant differences between intact and gonadectomised groups in layers II–VI but not layer I. **p b 0.01, ***p b 0.001.
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expression levels of TrkB full length mRNA (TrkB.TK+) or truncated
TrkB (TrkB.TK−) (data not shown), Pearson's correlations between
expression of TrkB transcripts and circulating testosterone levels in
the intact group revealed a negative correlation between circulating
testosterone and the TrkB TK+/TK− ratio (r = −0.84, p = 0.036)
(Fig. 3C).
3.3. Gonadectomy and testosterone replacement changed expression levels
of SST mRNA only in rat frontal cortex and did not change interneuron
mRNAs in rhesus macaque frontal cortex
We detected a signiﬁcant change in gene expression level in one out
of four interneuron speciﬁc markers in the rodent prefrontal cortex
following gonadectomy and testosterone replacement and detected no
gene expression changes in any of these markers in monkey prefrontal
cortex following gonadectomy.
In rat cortex, there was a signiﬁcant change due to treatment group
in SST mRNA expression [F(2,43) = 3.17, p = 0.05] (Fig. 4A). Post hoc
tests revealed that gonadectomy reduced SST mRNA levels (Intact vs.
Gdx, p=0.035), however; this reductionwas not prevented by testoster-
one replacement (Intact vs.Gdx+T, p= 0.034; Gdx vs.Gdx+ T p=ns)Fig. 2. Inmale rats testosterone replacement reversed the gonadectomy-induced increase in BD
the frontal cortex. Data are means ± SEM, expressed as a percentage of the intact group. * p ≤(Fig. 4A). Pearson's correlations revealed in the testosterone replaced
rat group (Gdx + T) that there was a signiﬁcant positive relationship
between testosterone and SST mRNA (r = 0.65, p = 0.04) (Fig. 4B,
Table 2) and a signiﬁcant negative relationship between testosterone
and calretinin mRNA (r =−0.74; p = 0.01) (Table 2). There were no
signiﬁcant changes due to treatment group in PV [F(2,42) = 2.19,
p = 0.13], CB [F(2,43) = 0.88, p = 0.42] or CR expression
[F(2,43) = 2.64, p = 0.08] in the rat PFC (data not shown).
In themonkey PFC, there were no signiﬁcant changes in PV [t(10)=
0.075, p=0.94], SST [t(10)=0.14, p=0.89], CB [t(9)=0.69, p=0.51]
or CR [t(10) = 0.58, p = 0.57] gene expression (data not shown). In
the Intact monkey group, Pearson's correlations between circulating
average pm testosterone and interneuron gene expression revealed
no signiﬁcant relationships (Table 2).
3.4. Circulating sex steroids alter the relationship between interneuron
marker mRNA and BDNF/TrkB mRNA expression in the rat and monkey
frontal cortices
In order to determine if the relationship between interneuronmarker
gene expression and BDNF/TrkB mRNA expression depended on the sex
steroid environment, we separated monkeys into treatment groupsNF IIa mRNA (A) and reduced BDNF VImRNA (B) relative to the gonadectomised group in
0.05.
Fig. 3.Testosteronemodulates TrkB transcripts in rat andmonkey frontal cortices. A. In the rat cortex testosterone replacement reduced expression of TrkB.T2mRNA. The TrkB FL:T2mRNA
ratio was reduced by gonadectomy and this was prevented by testosterone replacement. Data are means ± SEM, expressed as a percentage of the intact group. B. In the monkey cortex
there was a negative association between the ratio of TrkB TK+:TK−mRNA and average nighttime circulating testosterone levels (r =−0.84, p = 0.03). * p ≤ 0.05, ** p b 0.01.
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Gdx+T) and thosewithout (Gdx) testosterone and ran correlation anal-
yses within each group (Table 3: monkey; Table 4: rat).
In themonkey prefrontal cortex, Pearson's correlations revealedmany
positive relationships between interneuron marker gene expression and
BDNF and TrkB.TK+ transcript expression in the presence of testosterone
that were not evident when testosterone was absent (Table 3). This
pattern was most evident for correlations with BDNF/TrkB transcripts
and SST gene expression, but was also found with CR and BDNF I, and
with CB and TrkB TK+/TK−. Conversely,when testosteronewas absent,
a signiﬁcant positive correlation between PVmRNA and TrkB.TK+mRNA
was revealed that was not present in the intact group.
In the rat cortex, Pearson's correlations revealed some negative
correlations between interneuron markers and BDNF transcripts that
depended on the presence of testosterone (Table 4). In particular, only
in the presence of testosterone, SST mRNA was negatively correlated
with BDNF IIc mRNA and PV mRNA was negatively correlated with
BDNF IV and VI mRNA transcripts. When testosterone was removed,
TrkB.FL mRNA was signiﬁcantly positively correlated with CB mRNA
and CR mRNA was negatively correlated with BDNF IIa and BDNF VI
mRNAs.
4. Discussion
This study sought to determine if circulating testosterone during
normal adolescence modulates cortical gene expression of BDNF and
TrkB splice variants and whether this was related to gene expression
of speciﬁc cortical interneuronmarkers. We show that, in both monkey
and rat, testosterone removal over adolescence increased gene expres-
sion of speciﬁc BDNF transcripts, and testosterone replacement could
prevent the increase in BDNFmRNA. The study also revealed similarities
and differences in changes in TrkB mRNA levels by testosterone be-
tween species. The total level of TrkB full lengthmRNAwas not changed
by testosterone in rat PFC. The TrkB full length to truncated ratio in-
creased in rat cortex when testosterone was present. If these changes
were also reﬂected at the protein level, there may be more chance forFig. 4. A. In male rats gonadectomy reduced SST mRNA expression in the frontal cortex but thi
percentage of the intact group. B. In the Gdx + T group there was a positive correlation betweclassical TrkB signalling to be initiated by ligand binding when testos-
terone is present. We identiﬁed what appeared to be species-speciﬁc
relationships between interneuron markers and BDNF/TrkB gene ex-
pression that were dependent on the presence of testosterone in the
rat and monkey cortices, e.g., speciﬁc BDNF transcripts were positively
correlated with SST mRNA in themonkey but were negatively correlat-
ed with SST mRNA in the rat. Taken together, our ﬁndings suggest that
there are dynamic relationships between BDNF/TrkB and interneuron
markers that are dependent on the presence of testosterone and
may contribute to interneuron health and cortical maturation during
normal/healthy adolescence. The fact that BDNF mRNA is modulated
by testosterone in the mammalian cortex during this developmental
stage demonstrates that the sex steroid driven change of BDNF is
possible, but does not predict the direction of change or alteration in
schizophrenia.
A mature pattern of innervation by GABAergic synapses is not
achieved until late childhood or adolescence in both rodents and
primates (Morales et al., 2002; Chattopadhyaya et al., 2004; Lewis
et al., 2004a; Di Cristo, 2007; Fung et al., 2010; Catts et al., 2013). As a
main feature of adolescence is an increase in circulating sex hormones,
it follows that sex hormones may contribute to the ﬁnal maturation of
cortical inhibitory interneurons. Given that GABAergic neurons require
BDNF for maturation, and testosterone can induce BDNF in adults
(Rasika et al., 1999), it was surprising that testosterone over adoles-
cence decreased gene expression of some BDNF transcripts (BDNF II
and VI) in the mammalian cortex, suggesting that BDNF may become
more limited in supply during adolescence. This may have implications
for GABAergic health and thus, cognition at adolescence as abnormally
reduced BDNF action is associated with impaired spatial memory in
male rats (Mu et al., 1999). Within the context of normal development,
this decrease in speciﬁc BDNF transcripts due to testosterone may not
have detrimental effects on cognition and indeed be part of the ﬁne-
tuning of cortical maturation, or part of a normal closing of develop-
mental windows of increased plasticity. However, in circumstances
where there is an underlying predisposition to cognitive dysfunction
(such as genetic predisposition to schizophrenia) this testosterone-s was not prevented by testosterone replacement. Data are means ± SEM, expressed as a
en SST mRNA gene expression and testosterone level (r = 0.65, p = 0.04). * p ≤ 0.05.
Table 2
Correlations between serum testosterone and interneuron marker gene expression in the
frontal cortex in monkey and rat. Pearson's correlations between average nighttime
testosterone in the intactmonkeys revealed a trend for a negative correlationwith CBgene
expression only. In the testosterone-replaced rat group, Pearson's correlations revealed a
signiﬁcant positive correlation with SST and a signiﬁcant negative correlation with CR
with terminal circulating testosterone.
Testosterone
average pm vs.
Intact monkey Terminal
testosterone vs.
Gdx + T
r value p value r value p value
SST −0.61 0.20 SST 0.65 0.04⁎
CB −0.85 0.07 CB 0.21 0.54
PV −0.17 0.74 PV −0.26 0.44
CR −0.15 0.78 CR −0.74 0.01⁎
⁎ p ≤ 0.05.
Table 4
Correlations between interneuronmarker gene expression and BDNF/TrkB transcript mRNA
expression, in the frontal cortex within intact and gonadectomised + testosterone (com-
bined) and gonadectomised rat groups. The relationship between the expression of several
BDNF/TrkB transcript mRNAs and the expression of interneuronmarker mRNAs was altered
by the presence or absence of adolescent testosterone.
Intact and Gdx + T Gdx
r value p value r value p value
SST vs. BDNF I 0.10 0.60 0.35 0.21
SST vs. BDNF IIa 0.20 0.26 −0.02 0.95
SST vs. BDNF IIb 0.19 0.30 0.24 0.41
SST vs. BDNF IIc −0.45 0.01⁎ 0.39 0.17
SST vs. BDNF IV 0.21 0.27 0.30 0.31
SST vs. BDNF VI −0.35 0.07 0.18 0.53
SST vs. TrkB.FL 0.14 0.44 0.19 0.49
SST vs. TrkB.T1 0.05 0.76 −0.21 0.47
SST vs. TrkB.T2 0.29 0.11 0.10 0.72
SST vs. TrkB.FL/T1 0.05 0.78 0.31 0.27
SST vs. TrkB.FL/T2 0.18 0.33 −0.04 0.90
CB vs. BDNF I −0.19 0.33 0.49 0.08
CB vs. BDNF IIa 0.12 0.51 0.26 0.36
CB vs. BDNF IIb 0.08 0.65 0.16 0.60
CB vs. BDNF IIc 0.32 0.08 0.17 0.56
CB vs. BDNF IV −0.06 0.76 0.39 0.17
CB vs. BDNF VI 0.23 0.22 0.22 0.45
CB vs. TrkB.FL 0.25 0.16 0.54 0.04⁎
CB vs. TrkB.T1 0.34 0.05 0.14 0.65
CB vs. TrkB.T2 0.28 0.12 0.33 0.26
CB vs. TrkB.FL/T1 −0.13 0.48 −0.07 0.80
CB vs. TrkB.FL/T2 −0.22 0.22 0.43 0.12
PV vs. BDNF I −0.22 0.26 −0.30 0.32
PV vs. BDNF IIa 0.04 0.85 −0.01 0.96
PV vs. BDNF IIb −0.07 0.85 −0.16 0.61
PV vs. BDNF IIc −0.26 0.16 −0.09 0.78
PV vs. BDNF IV −0.50 0.01⁎ 0.15 0.63
PV vs. BDNF VI −0.50 0.006⁎⁎ 0.02 0.9
PV vs. TrkB.FL 0.13 0.5 −0.3 0.29
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consequences for interneurons and we speculate that this may contrib-
ute to the presentation and/or progression of cognitive deﬁcits that typ-
ically emerge in schizophrenia during adolescence in males.
Although some transcripts were decreased by testosterone in both
monkey and rat the relationships between BDNF/TrkB gene expression
and interneuron marker gene expression diverged between the two
species. In themonkey cortex, we found a positive relationship between
the level of BDNF transcript expression and SST mRNA within intact
animals. This aligns with full length TrkB mRNA and SST mRNA also
being positively correlated in intact animals. The actual full length
TrkB action would depend on the subcellular location of the TrkB iso-
forms and whether the truncated isoform was dimerising with TrkB.FL
and therefore curtailing classic TrkB second messenger signalling path-
ways and/or acting as a BDNF sink and/or initiating other truncated TrkB
independent functions (Fenner, 2012). A large proportion of SST+ in-
terneurons also express CB (Di Cristo, 2007). The expression of twoTable 3
Correlations between interneuron marker gene expression and BDNF/TrkB transcript
mRNA expression in the cortex within intact and gonadectomised monkey groups. The
relationship between the expression of several BDNF/TrkB transcript mRNAs and the
expression of interneuron marker mRNAs was altered by the presence or absence of ado-
lescent testosterone.
Intact Gdx
r value p value r value p value
SST vs. BDNF I 0.75 0.08 0.45 0.37
SST vs. BDNF II 0.75 0.08 0.49 0.32
SST vs. BDNF IV 0.81 0.05⁎ 0.11 0.8
SST vs. BDNF VI 0.80 0.06 0.8 0.06
SST vs. TrkB.TK+ 0.85 0.03⁎ −0.12 0.81
SST vs. TrkB.TK− −0.34 0.52 −0.67 0.15
SST vs. TK+/TK− −0.79 0.06 −0.64 0.17
CB vs. BDNF I 0.59 0.29 0.17 0.75
CB vs. BDNF II 0.37 0.53 0.20 0.70
CB vs. BDNF IV 0.84 0.07 0.23 0.66
CB vs. BDNF VI 0.83 0.08 0.10 0.86
CB vs. TrkB.TK+ 0.65 0.24 0.24 0.65
CB vs. TrkB.TK− −0.99 0.001⁎⁎ −0.004 0.99
CB vs. TK+/TK− 0.91 0.03⁎ 0.37 0.47
PV vs. BDNF I 0.76 0.08 −0.38 0.45
PV vs. BDNF II 0.50 0.30 0.25 0.63
PV vs. BDNF IV 0.37 0.47 0.05 0.93
PV vs. BDNF VI 0.30 0.56 −0.57 0.24
PV vs. TrkB.TK+ 0.47 0.34 0.88 0.02⁎
PV vs. TrkB.TK− −0.07 0.89 0.79 0.06
PV vs. TK+/TK− 0.36 0.48 0.31 0.55
CR vs. BDNF I 0.95 0.003⁎⁎ 0.27 0.60
CR vs. BDNF II −0.05 0.9 −0.13 0.80
CR vs. BDNF IV 0.63 0.18 0.21 0.69
CR vs. BDNF VI 0.45 0.37 0.09 0.95
CR vs. TrkB.TK+ 0.46 0.36 −0.10 0.86
CR vs. TrkB.TK− −0.35 0.49 −0.70 0.75
CR vs. TK+/TK− 0.54 0.27 0.08 0.89
⁎ p ≤ 0.05.
⁎⁎ p b 0.01.
PV vs. TrkB.T1 −0.14 0.45 −0.49 0.08
PV vs. TrkB.T2 −0.01 0.97 −0.20 0.49
PV vs. TrkB.FL/T1 0.32 0.08 0.05 0.87
PV vs. TrkB.FL/T2 0.08 0.67 0.24 0.42
CR vs. BDNF I −0.16 0.41 −0.05 0.87
CR vs. BDNF IIa −0.18 0.34 −0.66 0.008⁎⁎
CR vs. BDNF IIb −0.33 0.07 −0.11 0.71
CR vs. BDNF IIc −0.19 0.31 −0.05 0.86
CR vs. BDNF IV −0.03 0.11 −0.41 0.15
CR vs. BDNF VI −0.21 0.27 −0.54 0.04⁎
CR vs. TrkB.FL −0.19 0.31 −0.10 0.72
CR vs. TrkB.T1 −0.30 −0.10 −0.27 0.35
CR vs. TrkB.T2 −0.24 0.21 0.24 0.39
CR vs. TrkB.FL/T1 0.23 0.22 0.02 0.94
CR vs. TrkB.FL/T2 0.20 0.29 −0.05 0.88
⁎ p ≤ 0.05.
⁎⁎ p b 0.01.BDNF transcripts (IV, VI) was positively correlated with CB in intact
monkeys only and CB expression was positively correlated with the
TrkB FL/TK− ratio. So in the SST+/CB+ interneurons there may be
complex relationships between SST/CB gene expression and BDNF and
TrkB gene expressionwhich are only found in the presence of testoster-
one, as these correlations were not found in gonadectomised monkeys.
This complex interaction may be a mechanism whereby the timing of
the maturation of these neurons that synapse with pyramidal neuron
dendrites is controlled over adolescence in the primate cortex.
In the rat cortex, therewere fewer relationships between SST/CB and
BDNF/TrkB than in themonkey cortex both in the presence or absence of
testosterone. In contrast to the monkey, in the presence of testosterone
BDNF IIc (and BDNF VI)mRNA in the rat cortexwas negatively correlated
with SST mRNA but, as in the monkey, positively correlated (BDNF IIc
only) with CB. This may indicate a switch between predominantly
expressing SST mRNA to predominantly expressing CB mRNA that is in-
ﬂuencedby testosterone andmay reﬂect the different developmental tra-
jectories of the interneurons (Fung et al., 2010). No signiﬁcant or distinct
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the presence or absence of testosterone were identiﬁed in rats. This is
partly in line with the model of Glorioso et al. (2006) who showed that
SST expression was unchanged in male adult mouse cortex when TrkB
was reduced, however their model also showed that SST was decreased
when BDNF was decreased (Glorioso et al., 2006). However, their
model is in adult mice rather than adolescence and there may be crucial
differences in the relationships between BDNF and interneuron markers
during adolescent cortical maturation and adulthood.
PV neurons are the second population of interneurons that are consis-
tently reduced in schizophrenia. It has previously been reported that PV
neurons are less dependent on BDNF for the maintenance of phenotype
(Glorioso et al., 2006), although it has also been reported that approxi-
mately 80% of PV neurons express TrkB (Gorba and Wahle, 1999). Also,
in mice, when BDNF IV transcription was speciﬁcally blocked there
was a reduction in the number of PV neurons and impaired activity-
dependent BDNF expression (Sakata et al., 2009). We found that PV
mRNA appeared to be less broadly correlated than SST/CB mRNA with
BDNF mRNAs in the monkey cortex and although there was more co-
regulation of PV and BDNF mRNA in the rodent cortex in the presence
of testosterone this was restricted to the mRNA derived from two
BDNF promoters (BDNF IV and VI mRNAs). Calretinin expression in
the cortex was the least correlated with BDNF and TrkB expression in
the presence of testosterone. Indeed, studies in rodent have assessed
that b20% of CR neurons express TrkB (Gorba and Wahle, 1999). No
signiﬁcant relationships with CR mRNA and BDNF/TrkB mRNAs were
identiﬁed in the rat in the presence of testosterone, although in the
monkey there was a strong positive correlation between BDNF I and
CR mRNA that was dependent on testosterone. However, in the rat
cortex, when testosterone was removed a negative relationship be-
tween CR mRNA and BDNF IIa and VI mRNAs was revealed. This may
indicate that in the preadolescent, immature rodent cortex there is a
suppression of CR expression by BDNF and that relationship may
become uncoupled when testosterone increases at adolescence. Our
study indicates that the relationship between testosterone and its regu-
lation of BDNF and TrkB and thus, cortical neuron maturation is not a
linear relationship but may rather be a complex interplay of differential
regulation of BDNF/TrkB in distinct cortical interneuron populations.
Determining how testosterone contributes to cortical development
in the healthy adolescent brain will assist in determining how, or indeed
if, testosterone contributes to the derailment of normal development in
individuals who may be susceptible to developing schizophrenia. This
knowledge could aid the development of sex steroid based interventions
to protect healthy cortical neuron development/maturation or to correct
a derailed cortical system following diagnosis. Indeed, sex steroid based
adjunctive treatment of schizophrenia patients with a selective
oestrogen receptor modulator, raloxifene, has shown promising en-
hancement of cognitive function (Weickert et al., 2015). Future preclini-
cal investigations will allow us to determine whether this is due to a
modulation of the BDNF/TrkB/interneuron relationships identiﬁed here.
There are limitations in our study to be considered. We have identi-
ﬁed differences in the relationships between BDNF/TrkB gene expression
and interneuronmarkers between species andwe have identiﬁed impor-
tant similarities (e.g., gonadectomy increased BDNF transcripts). The dif-
ferences between rat and monkey may be due to species differences e.g.,
species differences in the BDNF gene (Pruunsild et al., 2007). The differ-
ences betweenprimates and rodentsmay also be due todifferences in ex-
perimental design. Although the experimental interval of testosterone
manipulation represented a similar period of time in terms of adolescent
development, the time pointswe investigated in the two speciesmay not
be exactly equivalent with regard to timing of changes in the cortex
(weeks in rats compared tomonths inmonkeys).Wemust also acknowl-
edge that circulating testosterone levels in the testosterone-replaced rats
reached supra-physiological levels. It is also a limitation in our study that
we have carried out multiple correlations without corrections and these
studies require follow-up and repetition.Wereport here that complex relationships exist between BDNF/TrkB
gene expression and interneuron marker gene expression that appear
to be dependent on the presence of testosterone at adolescence. Pertur-
bations in these relationships, thatmay occur due to genetic or environ-
mental factors that are associatedwith risk for schizophrenia, couldwell
derail normal cortical brain development and contribute to cortical
deﬁcits apparent in schizophrenia. Indeed, BDNF genetic variants
(Val66Met) may confer susceptibility to schizophrenia (Jonsson et al.,
2006) that could be unmasked at adolescence. Cortical BDNF mRNA is
lower (Weickert et al., 2003; Wong et al., 2010; Ray et al., 2014) and
truncated TrkB may be increased (Wong et al., 2013) in schizophrenia.
Suboptimal sex steroid signalling has been linked to schizophrenia in
the form of a dominant negative variant of the oestrogen receptor
(ER) (Perlman et al., 2005; Weickert et al., 2008). As testosterone in
the male can act via androgen receptor and/or be aromatized to
oestrogen and act via ERs, the presence of this ER variant confers risk
to both genders. Reductions in cortical interneuron health have been
implicated in schizophrenia (Lewis et al., 2005). We therefore propose
that any of these factors may contribute to the disruption of the appro-
priate relationships between testosterone/BDNF/interneurons in
schizophrenia. Given that we found that BDNF transcription can be
changed normally in male adolescence this demonstrates that BDNF is
a testosterone target in mammalian cortex; however, it does not allow
us to determine the nature of a putative testosterone/BDNF/interneuron
dysregulation in schizophrenia. Thus we speculate that we have demon-
strated that it is possible that increased testosterone-induced changes in
adolescence may precipitate or contribute to the progression of schizo-
phrenia. As highlighted, adolescence is a risk period for schizophrenia,
however it is also a risk period for other mental illnesses, including de-
pression, anorexia nervosa and anxiety, someofwhich aremore common
in females. This emphasises that sex steroid signallingmayplay some role
in theprecipitation ofmanydisorders. The fact that schizophrenia ismore
prevalent in males supports the suggestion that testosterone may play a
speciﬁc role in the precipitation/progression of schizophrenia. Preclinical
studies are required to determine how testosterone modulates BDNF/
TrkB/interneuron relationships in schizophrenia-like models. As such,
we conclude that the complex relationships between BDNF/TrkB and
interneurons aremodulated by testosterone during normal adolescence
and may be critical for cortical interneuron maturation, particularly
during the adolescent developmental window.
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